{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:09:39Z","timestamp":1790208579525,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00540-009-0746-3","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T12:10:52Z","timestamp":1250165452000},"page":"341-346","source":"Crossref","is-referenced-by-count":17,"title":["Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47"],"prefix":"10.1007","volume":"23","author":[{"given":"Takako","family":"Migita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mukaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Haraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,14]]},"reference":[{"key":"746_CR1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/14622416.9.11.1657","volume":"9","author":"K.M. Stowell","year":"2008","unstructured":"Stowell KM. Malignant hyperthermia: a pharmacogenetic disorder. Pharmacogenomics. 2008;9:1657\u20131672.","journal-title":"Pharmacogenomics"},{"key":"746_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","volume":"26","author":"N. Monnier","year":"2005","unstructured":"Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Rom\u00e9ro N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum Mutat. 2005;26: 413\u2013425.","journal-title":"Hum Mutat"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R. Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins PM. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006;27:977\u2013989.","journal-title":"Hum Mutat"},{"key":"746_CR4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"M.C.A. Ibarra","year":"2006","unstructured":"Ibarra MCA, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, Noguchi S, Hayashi TK, Ochiai R, Nishino I. Malignant hyperthermia in Japan. Anesthesiology. 2006;104:1146\u20131154.","journal-title":"Anesthesiology"},{"key":"746_CR5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/brain\/awl077","volume":"129","author":"S. Wu","year":"2006","unstructured":"Wu S, Ibarra CAM, Malicdan MCV, Murayama K, Ichihara Y, Kikuchi H, Nosaka I, Noguchi S, Hayashi YK, Nishino I. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006;129:1470\u20131480.","journal-title":"Brain"},{"key":"746_CR6","first-page":"148","volume":"22S","author":"D.C. Kim","year":"2008","unstructured":"Kim DC, Kim DS. Mutation screening of the entire ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families. J Anesth. 2008;22S:148.","journal-title":"J Anesth"},{"key":"746_CR7","unstructured":"http:\/\/www.emhg.org\/index.php?option=com_content&task=view&id=60&Itemid=86 . Accessed Dec 4 2008."},{"key":"746_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0076-6879(88)57064-7","volume":"157","author":"M. Endo","year":"1988","unstructured":"Endo M, Iino M. Measurement of Ca release in skinned fibers from skeletal muscle. Methods Enzymol. 1988;157:12\u201326.","journal-title":"Methods Enzymol"},{"key":"746_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00540-006-0495-5","volume":"21","author":"T. Migita","year":"2007","unstructured":"Migita T, Mukaid K, Kawamoto M, Kobayashi M, Yuge O. Fulminant- type malignant hyperthermia in Japan: cumulative analysis of 383 cases. J Anesth. 2007;21:285\u2013258.","journal-title":"J Anesth"},{"key":"746_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s005400050002","volume":"14","author":"S. Oku","year":"2000","unstructured":"Oku S, Mukaida K, Nosaka S, Sai Y, Maehara Y, Yuge O. Comparison of the in vitro caffeine-holothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. J Anesth. 2000;14:6\u201313.","journal-title":"J Anesth"},{"key":"746_CR11","doi-asserted-by":"crossref","first-page":"26 332","DOI":"10.1074\/jbc.272.42.26332","volume":"272","author":"J. Tong","year":"1997","unstructured":"Tong J, Oyamada H, Demaurex N, Grinstein S, McCarthy TV, MacLennan DHJ. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease. Biol Chem. 1997;272:26 332\u2013339.","journal-title":"Biol Chem"},{"key":"746_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-0004.2002.620206.x","volume":"62","author":"M. Wehner","year":"2002","unstructured":"Wehner M, Rueffert H, Koening F, Neuhaus J, Olthoff D. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation. Clin Genet. 2002;62:135\u2013146.","journal-title":"Clin Genet"},{"key":"746_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1213\/01.ANE.0000118110.90277.D2","volume":"99","author":"L.G. Weigl","year":"2004","unstructured":"Weigl LG, Ludwig-Papst C, Kress HG. 4-Chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility. Anesth Analg. 2004;99:103\u2013107.","journal-title":"Anesth Analg"},{"key":"746_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0143-4160(03)00072-1","volume":"34","author":"M. Wehner","year":"2003","unstructured":"Wehner M, Rueffert H, Koening F, Meinecke CD, Olthoff D. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes. Cell Calcium. 2003;34:163\u2013168.","journal-title":"Cell Calcium"},{"key":"746_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0b013e318182a93b","volume":"109","author":"A. Kaufmann","year":"2008","unstructured":"Kaufmann A, Kraft B, Michalek-Sauberer A, Weigl LG. Novel ryanodine receptor mutation that may cause malignant hyperthermia. Anesthesiology. 2008;109:457\u2013464.","journal-title":"Anesthesiology"},{"key":"746_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.274.2.693","volume":"274","author":"J. Tong","year":"1999","unstructured":"Tong J, McCarthy TV, McLennan DH. Measurement of resting cytosolic Ca2+ concentration and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. J Biol Chem. 1999;274:693\u2013702.","journal-title":"J Biol Chem"},{"key":"746_CR17","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/9.18.2599","volume":"9","author":"N. Monnier","year":"2000","unstructured":"Monnier N, Romero NB, Lerale J, Nivoche Y, Qi D, MacLennan DH, Fardeau M, Lunardi J. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet. 2000;9:2599\u2013608.","journal-title":"Hum Mol Genet"},{"key":"746_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"A. Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S for the European Malignant Hyperthermia Group. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth. 2001;86:283\u2013287.","journal-title":"Br J Anaesth"},{"key":"746_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","volume":"102","author":"N. Sambuughin","year":"2005","unstructured":"Sambuughin N, Holley H, Muldoon S, Brandom BW, de Bantel AM, Tobin JR, Nelson TE, Goldfarb LG. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. Anesthesiology. 2005;102:515\u2013521.","journal-title":"Anesthesiology"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-009-0746-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-009-0746-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-009-0746-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:43:53Z","timestamp":1559083433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-009-0746-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s00540-009-0746-3","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}